ATE414522T1 - Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure - Google Patents

Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure

Info

Publication number
ATE414522T1
ATE414522T1 AT04761743T AT04761743T ATE414522T1 AT E414522 T1 ATE414522 T1 AT E414522T1 AT 04761743 T AT04761743 T AT 04761743T AT 04761743 T AT04761743 T AT 04761743T AT E414522 T1 ATE414522 T1 AT E414522T1
Authority
AT
Austria
Prior art keywords
spares
strains
hyaluronic acid
treating acute
excessive exercise
Prior art date
Application number
AT04761743T
Other languages
English (en)
Inventor
Robert John Petrella
Original Assignee
Robert John Petrella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert John Petrella filed Critical Robert John Petrella
Application granted granted Critical
Publication of ATE414522T1 publication Critical patent/ATE414522T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04761743T 2003-10-09 2004-08-27 Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure ATE414522T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51068403P 2003-10-09 2003-10-09

Publications (1)

Publication Number Publication Date
ATE414522T1 true ATE414522T1 (de) 2008-12-15

Family

ID=34421822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761743T ATE414522T1 (de) 2003-10-09 2004-08-27 Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure

Country Status (14)

Country Link
US (1) US20050080037A1 (de)
EP (1) EP1677806B1 (de)
JP (4) JP2007507431A (de)
CN (1) CN1859918B (de)
AT (1) ATE414522T1 (de)
AU (1) AU2004277290B2 (de)
CA (1) CA2541813C (de)
DE (1) DE602004017888D1 (de)
DK (1) DK1677806T3 (de)
ES (1) ES2317018T3 (de)
PL (1) PL1677806T3 (de)
PT (1) PT1677806E (de)
SI (1) SI1677806T1 (de)
WO (2) WO2005032562A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2664334T3 (en) * 2004-12-30 2015-03-23 Genzyme Corp Intra-articular viscosupplement regimens
EP1968614A2 (de) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Behandlung von arthritis und andere muskel-und knochen-erkrankungen mit vernetzter hyaluronsäure
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
ES2332667T3 (es) * 2006-05-11 2010-02-10 Sandra Gobbo Mezclas binarias de acido hialuronico y uso terapeutico de las mismas.
CA2749034C (en) * 2009-01-07 2019-01-15 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
ES2665254T3 (es) 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
AU2013374192B2 (en) 2013-01-17 2018-11-08 Damian NAQVI Increasing muscular volume in a human using hyaluronic acid
CN106860706A (zh) * 2015-12-10 2017-06-20 仲伟波 双液删刺药液
RU2018141386A (ru) 2016-04-27 2020-05-27 Аника Терапьютикс, Инк. Композиция для применения в лечении дегенерации сухожилий

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ATE525076T1 (de) * 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel

Also Published As

Publication number Publication date
CA2541813A1 (en) 2005-04-14
CN1859918A (zh) 2006-11-08
US20050080037A1 (en) 2005-04-14
EP1677806B1 (de) 2008-11-19
WO2005034965A1 (en) 2005-04-21
DK1677806T3 (da) 2009-02-23
ES2317018T3 (es) 2009-04-16
JP2014205721A (ja) 2014-10-30
EP1677806A4 (de) 2007-04-04
PT1677806E (pt) 2009-01-29
JP2007507431A (ja) 2007-03-29
CA2541813C (en) 2011-12-06
AU2004277290B2 (en) 2010-05-13
AU2004277290A1 (en) 2005-04-14
JP2012236855A (ja) 2012-12-06
DE602004017888D1 (de) 2009-01-02
JP2016185989A (ja) 2016-10-27
PL1677806T3 (pl) 2009-05-29
CN1859918B (zh) 2010-07-07
WO2005032562A1 (en) 2005-04-14
EP1677806A1 (de) 2006-07-12
SI1677806T1 (sl) 2009-06-30

Similar Documents

Publication Publication Date Title
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE602005010213D1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
BR0010669A (pt) Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
SE0400184D0 (sv) New therapeutical use
EA201992759A1 (ru) Ассоциация, включающая кислород и гиалуроновую кислоту, для местного вагинального применения
SE0000601D0 (sv) Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
IS7912A (is) Notkun dókósahexensýru sem virks efnis til að meðhöndla fitukyrking
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
PT1251850E (pt) Utilizacao de uma preparacao de combinacao na terapia do cancro
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
MX2022009081A (es) Absorcion celular.
RU2532302C1 (ru) Способ лечения больных с эпикондилитом
RU2010144554A (ru) Средство для предотвращения и/или лечения сосудистых заболеваний
JO2586B1 (en) Use of different sulfamide derivatives combined with benzo ring for pain management

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1677806

Country of ref document: EP